A Guided Discussion: AJOVY: The Long-Acting Anti-CGRP Injection with Lasting Protection Against Migraine
Friday, June 10, 2022 6:30 AM to 7:30 AM · 59 min. (America/Denver)
Juniper Ballroom
Industry Event
Information
Industry-Sponsored Event
Sponsored by Teva Pharmaceutical
Not Eligible for CME Credits Susan Hutchinson, MD Orange County Migraine & Headache Center Brad Klein, MD, MBA, FAAN, FAHS, FAANEM Abington Neurological Associates
- Understand what makes AJOVY different
- Examine the clinical profile of AJOVY
- Review safety data from clinical trials
- Review dosing and administration options with the AJOVY autoinjector
